• Skip to primary navigation
  • Skip to main content

MN Associates, Inc.

Practical, high quality and rigorous research and evaluation to help institutions grow

  • About
    • About MNA
    • Team
  • Our Work
    • Focus Areas
    • Services
    • Clients
  • Work Samples
  • Publications
    • Technical Reports
    • Academic Publications
    • Conference Presentations
  • News and Updates
  • Contact

October 28, 2020

It’s Cool To Collaborate With A Molecular Geneticist!

It’s cool when you get to work on a grant proposal with a molecular geneticist with an expertise in genome engineering and editing (e.g., TALEN and CRISPR-Cas9 systems). What’s even cooler is when he also happens to be your college classmate!

I am honored to have the opportunity to collaborate (as an evaluator) with Anil Kumar Challa, Ph.D., my classmate from Banaras Hindu University (Varanasi, India) where we completed our Bachelor’s degree in Agricultural Sciences in the late 90s.

The recently National Science Foundation-funded, Improving Undergraduate STEM Education (IUSE) grant titled, Biology Education using Genome Engineering Technologies, at University of Alabama (UAB), will develop a cohort of teachers who will be able to successfully teach their students in underserved central Alabama high schools an understanding and initial skills through hands-on courses and lab-based experiences in advanced biology.

Anil, as Assistant Professor and a Co-PI on the grant, brings extensive knowledge and experience in experimental designs, project planning, communication, and documentation in genetics and molecular biology to the project. The PI of the grant is J. Michael Wyss.

A bit of genome editing 101.

Genome Editing is the ability to make specific changes at targeted genomic sites-is of fundamental importance to researchers in biology and medicine. Two genome editing technologies have emerged recently that exploit bacterial systems for plant pathogenesis or adaptive immunity: TALEN (Transcription Activator-Like Effector Nucleases) and CRISPR (Clustered, Regularly Interspaced, Short Palindromic Repeats), respectively. Both TALEN and CRISPR use endonucleases that initiate double-strand breaks (DSBs) at virtually any genomic target sequence, and are used for many applications, including gene knockout, transgene knock-in, gene tagging, and correction of genetic defects. While both technologies are popular, the decision to choose one technology over the other is not always clear.
(Source: https://www.genecopoeia.com/resource/genome-editing-talen-or-crispr/)

PC: National Cancer Institute/Unsplash.com

 

Filed Under: News and Updates

Kavita Mittapalli

Kavita Mittapalli, Ph.D., is the CEO of MN Associates, Inc. She brings over 18 years of experience in conducting research and evaluation for various programs and initiatives. She started MNA while in grad school at George Mason University (VA). An agriculture graduate turned applied sociologist and a mixed methodologist by training, Kavita brings her extensive qualitative and quantitative research skills to the evaluation work she does.

Click here to subscribe to the RSS feed for MNA news and updates or enter your email address below to have them emailed directly to your inbox.
 


© 2023 MN Associates, Inc. Website by David Keyes.